Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Luis Viladomiu"'
Autor:
Elena Allende, Itxarone Bilbao, Luis Viladomiu, Ramon Vilallonga, Ramón Charco, Sergi Quiroga, Carlos Margarit, Angeles Montero
Publikováno v:
Gastroenterología y Hepatología. 31:341-346
Krukenberg's tumor refers to unilateral or bilateral ovarian metastatic tumors whose origin may be known or unknown. The incidence of this type of tumor is difficult to evaluate but may represent between 3% and 8% of ovarian tumors. In most cases, th
Autor:
Jaime Guardia, Rosendo Jardi, Maria Buti, Montserrat Cotrina, Rafael Esteban, Helena Allende, Francisco Rodríguez, Luis Viladomiu
Publikováno v:
Journal of Medical Virology. 49:66-69
Eighty-six patients were followed for 6.5 years to study the epidemiological, virological, and histological course of chronic delta hepatitis and the relationship of this disease with HIV and HCV infection. Patients were classified into four groups a
Autor:
Maria Buti, Jaime Guardia, Rafael Esteban, Montserrat Cotrina, Luis Viladomiu, Rosendo Jardi, Francisco Rodriguez-Frias
Publikováno v:
Hepatology. 22:1641-1647
The precore-core gene of hepatitis B virus (HBV) was directly sequenced from serum samples of 42 patients with chronic B hepatitis (19 hepatitis B e antigen [HBeAg]+ and 23 anti-HBe+). Viral genotypes were determined by comparison with 11 reference s
Autor:
Hugo Troonen, Rafael Esteban, Rosendo Jardi, Maria Buti, J.I. Esteban, Francisco Rodriguez-Frias, Luis Viladomiu, Montserrat Cotrina, Jaime Guardia
Publikováno v:
Journal of Virological Methods. 55:49-54
In order to study the prevalence of hepatitis E virus (HEV) infection in developed countries, IgG and IgM anti-HEV were determined in serum samples from 382 patients with acute viral hepatitis (244 hepatitis A, 48 hepatitis B and/or D, and 90 non-A,
Autor:
Juan Genesca, Pedro Madoz, Xavier Vidal, Jose Manuel Hernández, Eduardo Muñiz, Josep Quer, Harvey J. Alter, Luis Viladomiu, J. Enríquez, Rafael Esteban, Xavier Torras, Antonio Gonzalez, Jaime Guardia, Juan Ignacio Esteban, James Wai-Kuo Shih
Publikováno v:
Scopus-Elsevier
Routine screening of blood donors for anti-hepatitis C virus (HCV) has been implemented in most developed countries. However, the independent efficacy of such screening has not been established in a controlled, prospective study. We tracked 478 patie
Autor:
Cathy Conry-Cantilena, Mark VanRaden, Joan Gibble, Jacqueline Melpolder, A. Obaid Shakil, Luis Viladomiu, Ling Cheung, Adrian DiBisceglie, Jay Hoofnagle, James W. Shih, Richard Kaslow, Paul Ness, Harvey J. Alter
Publikováno v:
The New England journal of medicine. 334(26)
For many people infected with the hepatitis C virus (HCV), the route of exposure, risk of transmission, and severity of associated liver disease are unknown. We studied these variables in people who donated blood voluntarily.Blood donors who tested p
Autor:
Luis Viladomiu, Jaime Guardia, Jorge Bartolomé, Rosendo Jardi, A. Olmos, Rafael Esteban, Juan Antonio Rodriguez, Maria Buti
Publikováno v:
American journal of nephrology. 12(3)
Although the efficacy of hepatitis B vaccines in patients under chronic hemodialysis treatment has been well documented, the persistence of immunity in this population remains largely unknown. In this study we have followed 60 hemodialysis patients u
Autor:
Pedro Madoz, J.C. Lopez-Talavera, Rafael Esteban, Juan Genesca, Juan Ignacio Esteban, Eduardo Muñiz, Manuel Rosell, Xavier Vidal, Helena Allende, Luis Viladomiu, Jose Manuel Hernández, Jaime Guardia, Antonio Gonzalez, Carmen Martin-Vega
Publikováno v:
Scopus-Elsevier
To determine the epidemiologic, clinical, serologic, and histologic importance of antibodies to hepatitis C virus (anti-HCV) in blood donors.Cross-sectional identification and prospective evaluation of seropositive donors; retrospective assessment of
Autor:
Jaime Guardia, José M. de la Torre Hernández, Antonio González, George Kuo, Maria Buti, Luis Viladomiu, Joan Genescà, Q-L. Choo, Rafael Esteban, Mercè Roget, J.C. Lopez-Talavera, Michael Houghton, Victor Vargas, J.I. Esteban
Publikováno v:
The Lancet. 334:294-297
The frequency of hepatitis C virus (HCV) infection in Spain was assessed by means of a recombinant-based immunoassay for serum anti-HCV antibodies. 836 serum samples were tested from 676 patients selected according to their risk of blood-borne viral
Autor:
Carmen Martin-Vega, Jose Manuel Hernández, Carmen Sánchez, Jaime Guardia, Rafael Esteban, Luis Viladomiu, David Lucea, Antonio Gonzalez, J.C. Lopez-Talavera, Xavier Vidal, Juan Ignacio Esteban
Publikováno v:
Scopus-Elsevier
The hepatitis C virus (HCV) is now known to be the chief cause of transfusion-associated non-A, non-B hepatitis, but the prevalence of HCV among blood donors and the frequency of transmission by blood transfusion are unknown.To assess the sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e49546bcdcda427f102aef9bf43c18
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025107267&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025107267&partnerID=MN8TOARS